Deciphering MET‐dependent modulation of global cellular responses to DNA damage by quantitative phosphoproteomics
Increasing evidence suggests that interference with growth factor receptor tyrosine kinase (RTK) signaling can affect DNA damage response (DDR) networks, with a consequent impact on cellular responses to DNA‐damaging agents widely used in cancer treatment. In that respect, the MET RTK is deregulated...
Main Authors: | Ariel Bensimon, Jonas P. Koch, Paola Francica, Selina M. Roth, Rahel Riedo, Astrid A. Glück, Eleonora Orlando, Andree Blaukat, Daniel M. Aebersold, Yitzhak Zimmer, Ruedi Aebersold, Michaela Medová |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-06-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.12696 |
Similar Items
-
The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response—Biological and Clinical Aspects
by: Michaela Medová, et al.
Published: (2013-12-01) -
PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models
by: Lluís Nisa, et al.
Published: (2017-05-01) -
Auto-renouvellement des cellules souches melanocytaires : rôle des kinases RAF et MET
by: Barbotin, Céline
Published: (2016) -
Roles of MET in Cancer Development and Treatment
Published: (2023) -
The c-Met Inhibitor MSC2156119J Effectively Inhibits Tumor Growth in Liver Cancer Models
by: Friedhelm Bladt, et al.
Published: (2014-08-01)